{"id":"lyumjev","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Hypoglycemia","drugRate":"","severity":"common","organSystem":""},{"effect":"Injection/infusion site reactions","drugRate":"","severity":"common","organSystem":""},{"effect":"Weight gain","drugRate":"","severity":"common","organSystem":""},{"effect":"Lipodystrophy","drugRate":"","severity":"common","organSystem":""},{"effect":"Pruritus","drugRate":"","severity":"common","organSystem":""},{"effect":"Rash","drugRate":"","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Severe hypoglycemia","drugRate":"","severity":"serious"},{"effect":"Anaphylaxis","drugRate":"","severity":"serious"},{"effect":"Angioedema","drugRate":"","severity":"serious"},{"effect":"Bronchospasm","drugRate":"","severity":"serious"},{"effect":"Hypotension","drugRate":"","severity":"serious"},{"effect":"Shock","drugRate":"","severity":"serious"},{"effect":"Generalized skin reactions","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1201538","moleculeType":"Protein"},"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Lyumjev","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:21:38.467487+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T02:21:53.318168+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:21:45.047904+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Lyumjev","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:21:45.899015+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Insulin receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:21:46.633566+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201538/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:21:46.375140+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"c5a056e2-b568-4ca6-9ed8-79c010942d00","title":"LYUMJEV (INSULIN LISPRO-AABC) INJECTION, SOLUTION LYUMJEV KWIKPEN (INSULIN LISPRO-AABC) INJECTION, SOLUTION LYUMJEV JUNIOR KWIKPEN (INSULIN LISPRO-AABC) INJECTION, SOLUTION LYUMJEV TEMPO PEN (INSULIN LISPRO-AABC) INJECTION, SOLUTION LYUMJEV KWIKPEN (INSULIN LISPRO-AABC) INJECTION, SOLUTION [ELI LILLY AND COMPANY]"},"aiSummary":"Lyumjev, developed by the McGill University Health Centre and its Research Institute, is a marketed drug primarily indicated for Type 1 diabetes mellitus. A key strength of Lyumjev is its unique mechanism, which differentiates it in the diabetes treatment landscape. The primary risk is the expiration of its key composition patent in 2028, potentially leading to increased competition from generics.","ecosystem":[],"mechanism":{"target":"Insulin receptor"},"_scrapedAt":"2026-03-28T03:51:07.195Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T02:21:53.318496+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Diabetes mellitus type 1","diseaseId":"diabetes-mellitus-type-1","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Diabetes mellitus type 2","diseaseId":"diabetes-mellitus-type-2","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06948760","phase":"NA","title":"Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D","status":"COMPLETED","sponsor":"Mark D. DeBoer, MD, MSc., MCR","startDate":"2025-07-23","conditions":"Type 1 Diabetes","enrollment":11},{"nctId":"NCT05508061","phase":"NA","title":"Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"Inreda Diabetic B.V.","startDate":"2022-10-19","conditions":"Type 1 Diabetes","enrollment":12},{"nctId":"NCT07341373","phase":"PHASE1","title":"A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500","status":"RECRUITING","sponsor":"Portal Diabetes, Inc.","startDate":"2026-01","conditions":"Type 1 Diabetes","enrollment":25},{"nctId":"NCT07090824","phase":"PHASE1","title":"Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"Stanford University","startDate":"2025-10-28","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus","enrollment":20},{"nctId":"NCT06370715","phase":"PHASE4","title":"A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2024-04-18","conditions":"Diabetes Mellitus, Type 2","enrollment":150},{"nctId":"NCT06854861","phase":"PHASE1, PHASE2","title":"Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes","status":"SUSPENDED","sponsor":"St. Olavs Hospital","startDate":"2025-04-01","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT05325294","phase":"NA","title":"Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2022-05-05","conditions":"Type 1 Diabetes","enrollment":244},{"nctId":"NCT06387199","phase":"PHASE2, PHASE3","title":"Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2024-12-01","conditions":"Type 1 Diabetes, Diabetes Mellitus","enrollment":26},{"nctId":"NCT06600776","phase":"PHASE4","title":"Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System","status":"NOT_YET_RECRUITING","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2024-10-06","conditions":"Type 1 Diabetes (T1D)","enrollment":50},{"nctId":"NCT05262387","phase":"PHASE1","title":"A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-02-14","conditions":"Diabetes Mellitus, Type 1","enrollment":25},{"nctId":"NCT05403502","phase":"NA","title":"Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2022-08-31","conditions":"Type 1 Diabetes","enrollment":183},{"nctId":"NCT06046417","phase":"PHASE2, PHASE3","title":"A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2023-11-30","conditions":"type1diabetes, Diabetes Mellitus, Type 1","enrollment":30},{"nctId":"NCT06021158","phase":"PHASE2","title":"A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2023-12-20","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes","enrollment":12},{"nctId":"NCT05660941","phase":"NA","title":"Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)","status":"UNKNOWN","sponsor":"Manchester University NHS Foundation Trust","startDate":"2023-07-21","conditions":"Diabetes Mellitus, Type 1","enrollment":26},{"nctId":"NCT03760640","phase":"PHASE2","title":"A Study of LY900014 in a Medtronic Pump","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2019-02-18","conditions":"Type1 Diabetes Mellitus","enrollment":42}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL1201538"},"formularyStatus":[],"_approvalHistory":[{"date":"20210813","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"BLA761109"},{"date":"20200615","type":"ORIG","sponsor":"ELI LILLY AND CO","applicationNumber":"BLA761109"},{"date":"20221014","type":"SUPPL","sponsor":"ELI LILLY AND CO","applicationNumber":"BLA761109"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":14,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Lyumjev","genericName":"Lyumjev","companyName":"McGill University Health Centre/Research Institute of the McGill University Health Centre","companyId":"mcgill-university-health-centre-research-institute-of-the-mcgill-university-heal","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T02:21:53.318496+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}